EVE-Vax: To Build Vaccines for Viruses That Don’t Even Exist Yet
EVE-Vax is a predictive artificial intelligence model. It uses evolutionary, biological, and also structural knowledge about a virus. The model can anticipate surface proteins that may appear as the pathogen evolves. It can also design these predicted proteins.
The researchers used EVE-Vax to create 83 new variants of the SARS-CoV-2 “spike” protein. These variants were completely novel designs. The spike protein is the main surface protein the virus uses to infect human cells. Each new variant contained a unique combination of up to ten mutations. No two variants were the same.
Youssef N., Gurev S., Ghantous F., Kelly P. B., Javier A. J., Nicole N. T., Dauphin A., Sherman A. C., Leonid Y., Dario S., Ralph E., Kotzen B., Pascal N., Aaron W. K., Alexander A. C., Sandra E. D., Jesse E., Deborah H. F., Pamela J. B., Jacob E. L., Jeremy L., Michael S. S., Debora S. M published their research under the title “Computationally designed proteins mimic antibody immune evasion in viral evolution” in June 2025.
ENTECH STEM Magazine has included this research in its list of the Top 10 Biotechnology Discoveries and Innovations of 2025.
Potential Benefits Of EVE-Vax
Vaccine Development and Optimization
- EVE-Vax can help not only researchers but also vaccine developers. It predicts the emergence of new viral surface proteins. This is also especially useful as the pathogen evolves and mutates.
- This information can guide the design and development of vaccines. It helps make vaccines more effective and also broadly protective. It also ensures they remain effective against emerging variants.
- By anticipating the mutational pathways of the virus, EVE-Vax can also contribute to the creation of universal or broadly cross-reactive vaccines, therefore, reducing the need for frequent updates and booster shots.
Pandemic Preparedness and Response

- The predictive capabilities of EVE-Vax can enhance pandemic preparedness efforts because it can allow researchers to anticipate the evolution of viral surface proteins and design pre-emptive countermeasures.
- This can lead to faster development and deployment of vaccines and therapeutics in the event of a new viral outbreak or pandemic, potentially saving lives and reducing the overall societal and economic impact.
Surveillance and Early Warning Systems
- The predictive power of EVE-Vax can be integrated into global disease surveillance networks to monitor the emergence of concerning viral variants, therefore, providing early warnings to public health authorities.
- This information can trigger timely interventions, such as the implementation of targeted containment measures or the acceleration of vaccine production, to mitigate the spread and impact of new viral threats
Educational and Career Opportunities
Computational and Artificial Intelligence in Virology
- Advancing the algorithms and machine learning techniques used in EVE-Vax in order to improve the accuracy, robustness, and interpretability of viral surface protein predictions
- Integrating EVE-Vax with other bioinformatics tools and data sources in order to enhance its capability to model the complex dynamics of viral evolution and adaptation
- Exploring the application of AI and deep learning approaches to other areas of virus research, such as drug discovery, disease surveillance, and outbreak prediction
Viral Evolutionary Dynamics and Genomics
- Studying the genetic, structural, and also functional factors that influence the mutational pathways and adaptive evolution of viral surface proteins
- Developing advanced computational and experimental methods to model and simulate the complex evolutionary trajectories of viruses
- Investigating the role of viral diversity, quasispecies dynamics, and host-pathogen interactions in shaping the emergence of new viral variants
Vaccine Design and Development
- leveraging the insights from EVE-Vax to design novel vaccine candidates that can elicit broad and durable immune responses against evolving viral threats
- Exploring the use of EVE-Vax predictions to guide the selection of optimal vaccine antigens and the development of universal or broadly cross-protective vaccines
- Evaluating the clinical efficacy and safety of EVE-Vax-informed vaccine candidates through rigorous preclinical and clinical trials
Reference
Youssef, N., Gurev, S., Ghantous, F., Brock, K. P., Jaimes, J. A., Thadani, N. N., … & Marks, D. S. (2025). Computationally designed proteins mimic antibody immune evasion in viral evolution. Immunity. DOI: 10.1016/j.immuni.2025.04.015
Additionally, to stay updated with the latest developments in STEM research, visit ENTECH Online. Basically, this is our digital magazine for science, technology, engineering, and mathematics. Also, at ENTECH Online, you’ll find a wealth of information.



